LUND, Sweden, Dec. 16, 2024 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, published positive results in the clinical validation of its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback